reviewMolecular CancerJan 9, 2025GOLD OA

Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy

Central South University · Xiangya Hospital Central South University

PubMed
Indexed incrossrefdoajpubmed

Abstract

Metabolic reprogramming within the tumor microenvironment (TME) is a hallmark of cancer and a crucial determinant of tumor progression. Research indicates that various metabolic regulators form a metabolic network in the TME and interact with immune cells, coordinating the tumor immune response. Metabolic dysregulation creates an immunosuppressive TME, impairing the antitumor immune response. In this review, we discuss how metabolic regulators affect the tumor cell and the crosstalk of TME. We also summarize recent clinical trials involving metabolic regulators and the challenges of metabolism-based tumor therapies in clinical translation. In a word, our review distills key regulatory factors and their…

No related works found for this paper.

Funding